Clinical Trials
2 trialsNCT07607054 2026-05-26
A First-in-human Phase I Study to Evaluate EMB-15 in Patients With Locally Advanced or Metastatic Solid Tumors.
Shanghai EpimAb Biotherapeutics Co., Ltd.
Phase 1 Not yet recruiting
NCT07318649 2026-01-06
Phase 2 Clinical Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of GH21 Capsules Combined With D-1553 Tablets in Subjects With Locally Advanced or Metastatic Solid Tumors With the KRASG12C Mutation
Suzhou Genhouse Bio Co., Ltd.
Phase 2 Not yet recruiting